Loncaric et al., 2020 - Google Patents
Broad-spectrum cephalosporin-resistant and/or fluoroquinolone-resistant enterobacterales associated with canine and feline urogenital infectionsLoncaric et al., 2020
View HTML- Document ID
- 3512927184420748057
- Author
- Loncaric I
- Misic D
- Szostak M
- Künzel F
- Schäfer-Somi S
- Spergser J
- Publication year
- Publication venue
- Antibiotics
External Links
Snippet
The aim of the present study was to characterize Enterobacterales resistant to 3rd and 4th generation cephalosporins, carbapenems and/or fluoroquinolones, isolated from dogs and cats with urogenital infections. In total, 36 strains (Escherichia coli (n= 28), Klebsiella …
- 201000009910 diseases by infectious agent 0 title abstract description 28
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/01—Social networking
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alegría et al. | Molecular diversity of ESBL-producing Escherichia coli from foods of animal origin and human patients | |
Kot et al. | Antibiotic resistance of uropathogens isolated from patients hospitalized in district hospital in central Poland in 2020 | |
Loncaric et al. | Broad-spectrum cephalosporin-resistant and/or fluoroquinolone-resistant enterobacterales associated with canine and feline urogenital infections | |
Massella et al. | Snapshot study of whole genome sequences of Escherichia coli from healthy companion animals, livestock, wildlife, humans and food in Italy | |
Kim et al. | Prevalence and molecular epidemiology of extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli from multiple sectors of poultry industry in Korea | |
Kyung-Hyo et al. | Antimicrobial resistance profiles of Escherichia coli from diarrheic weaned piglets after the ban on antibiotic growth promoters in feed | |
Nittayasut et al. | Multiple and high-risk clones of extended-spectrum cephalosporin-resistant and bla NDM-5-harbouring uropathogenic Escherichia coli from cats and dogs in Thailand | |
Bernreiter-Hofer et al. | The pheno-and genotypic characterization of porcine Escherichia coli isolates | |
Ma et al. | Antibiotic resistance in shiga toxigenic Escherichia coli isolates from surface waters and sediments in a mixed use urban agricultural landscape | |
Carvalho et al. | Antimicrobial resistance genes and diversity of clones among ESBL-and acquired AmpC-producing Escherichia coli isolated from fecal samples of healthy and sick cats in Portugal | |
Shnaiderman-Torban et al. | Extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized neonatal foals: prevalence, risk factors for shedding and association with infection | |
Elmoslemany et al. | Diversity and risk factors associated with multidrug and methicillin-resistant staphylococci isolated from cats admitted to a veterinary clinic in eastern province, Saudi Arabia | |
Salgado-Caxito et al. | Higher prevalence of extended-spectrum cephalosporin-resistant Enterobacterales in dogs attended for enteric viruses in Brazil before and after treatment with cephalosporins | |
Truong et al. | Genetic comparison of ESBL-producing Escherichia coli from workers and pigs at Vietnamese pig farms | |
Pérez-Etayo et al. | The aquatic ecosystem, a good environment for the horizontal transfer of antimicrobial resistance and virulence-associated factors among extended spectrum β-lactamases producing E. coli | |
Cherubini et al. | Resistome and virulome of multi-drug resistant E. coli ST131 isolated from residents of Long-Term Care Facilities in the Northern Italian Region | |
Mesquita et al. | An update on wastewater multi-resistant bacteria: Identification of clinical pathogens such as Escherichia coli O25b: H4-B2-ST131-producing CTX-M-15 ESBL and KPC-3 carbapenemase-producing Klebsiella oxytoca | |
Saleem et al. | The gut of healthy infants in the community as a reservoir of ESBL and carbapenemase-producing bacteria | |
Ramos et al. | Fecal shedding of multidrug resistant Escherichia coli isolates in dogs fed with raw meat-based diets in Brazil | |
Atlaw et al. | Identification of CTX-M type ESBL E. coli from sheep and their abattoir environment using whole-genome sequencing | |
Al-Quraini et al. | Assessment of in-vitro synergy of fosfomycin with meropenem, amikacin and tigecycline in whole genome sequenced extended and pan drug resistant Klebsiella Pneumoniae: exploring a colistin sparing protocol | |
Belas et al. | ESBL/p AmpC-producing Escherichia coli causing urinary tract infections in non-related companion animals and humans | |
Kocúreková et al. | Antimicrobial susceptibility and detection of virulence-associated genes in Escherichia coli strains isolated from commercial broilers | |
Jouini et al. | Lineages, virulence gene associated and integrons among extended spectrum β-lactamase (ESBL) and CMY-2 producing enterobacteriaceae from bovine mastitis, in Tunisia | |
Ibekwe et al. | Diversity of plasmids and genes encoding resistance to Extended-spectrum β-lactamase in Escherichia coli from different animal sources |